A significant insider transaction involving the exercise of company stock options was reported on November 12, by Nancy Ryan Gray, Director at Ligand Pharmaceuticals (NASDAQ:LGND), as per the latest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback